adenine has been researched along with Chronic Delta Hepatitis in 15 studies
Excerpt | Relevance | Reference |
---|---|---|
" The first choice of therapy in chronic hepatitis B infection can be pegylated interferon for 48 weeks or continuous entecavir or tenofovir therapy." | 3.80 | [Diagnosis and treatment of chronic hepatitis B and D. Hungarian national consensus guideline]. ( Gervain, J; Horváth, G; Hunyady, B; Lengyel, G; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I, 2014) |
"Interferon is the only effective treatment for chronic hepatitis D virus (HDV) infection." | 2.80 | Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome. ( Bozkaya, H; Dalekos, GN; Deda, X; Gürel, S; Heidrich, B; Idilman, R; Keskin, O; Manns, M; Pehlivan, S; Tabak, F; Tüzün, A; Wedemeyer, H; Yalçın, K; Yurdaydin, C; Zachou, K; Zeuzem, S, 2015) |
"Liver fibrosis was measured using elastometry." | 1.40 | Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients. ( Barreiro, P; Fernández-Montero, JV; Labarga, P; Mendoza, Cd; Sierra-Enguita, R; Soriano, V; Vispo, E, 2014) |
"Data on liver fibrosis evolution in HIV-HBV-coinfected patients treated with tenofovir disoproxil fumarate (TDF) are scarce." | 1.36 | Liver fibrosis changes in HIV-HBV-coinfected patients: clinical, biochemical and histological effect of long-term tenofovir disoproxil fumarate use. ( Bonnard, P; Boyd, A; Girard, PM; Lacombe, K; Lascoux-Combe, C; Lasnier, E; Meynard, JL; Miailhes, P; Molina, JM; Wendum, D, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (20.00) | 29.6817 |
2010's | 12 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brichler, S | 1 |
Setshedi, M | 1 |
Renou, C | 1 |
Gunsar, F | 1 |
Price, J | 1 |
Horváth, G | 1 |
Hunyady, B | 1 |
Gervain, J | 1 |
Lengyel, G | 1 |
Makara, M | 1 |
Pár, A | 1 |
Szalay, F | 1 |
Telegdy, L | 1 |
Tornai, I | 1 |
Soriano, V | 1 |
Vispo, E | 1 |
Sierra-Enguita, R | 1 |
Mendoza, Cd | 1 |
Fernández-Montero, JV | 1 |
Labarga, P | 1 |
Barreiro, P | 1 |
Keskin, O | 1 |
Wedemeyer, H | 3 |
Tüzün, A | 1 |
Zachou, K | 3 |
Deda, X | 1 |
Dalekos, GN | 2 |
Heidrich, B | 1 |
Pehlivan, S | 1 |
Zeuzem, S | 2 |
Yalçın, K | 1 |
Gürel, S | 2 |
Tabak, F | 1 |
Idilman, R | 1 |
Bozkaya, H | 2 |
Manns, M | 1 |
Yurdaydin, C | 3 |
Goyal, A | 1 |
Murray, JM | 1 |
Cholongitas, E | 1 |
Goulis, I | 1 |
Antoniadis, N | 1 |
Fouzas, I | 1 |
Imvrios, G | 1 |
Giakoustidis, D | 1 |
Giouleme, O | 1 |
Papanikolaou, V | 1 |
Akriviadis, E | 1 |
Vasiliadis, T | 1 |
Valencia, ME | 1 |
Moreno, V | 1 |
Mansour, W | 1 |
Ducancelle, A | 1 |
Le Gal, F | 1 |
Le Guillou-Guillemette, H | 1 |
Abgueguen, P | 1 |
Pivert, A | 1 |
Calès, P | 1 |
Gordien, E | 1 |
Lunel, F | 1 |
Boyd, A | 1 |
Lasnier, E | 1 |
Molina, JM | 1 |
Lascoux-Combe, C | 1 |
Bonnard, P | 1 |
Miailhes, P | 1 |
Wendum, D | 1 |
Meynard, JL | 1 |
Girard, PM | 1 |
Lacombe, K | 1 |
Erhardt, A | 1 |
Çakaloğlu, Y | 1 |
Değertekin, H | 1 |
Koch, A | 1 |
Bock, T | 1 |
Dienes, HP | 1 |
Manns, MP | 2 |
Grabowski, J | 1 |
Buggisch, P | 1 |
Hofmann, WP | 1 |
Jaroszewicz, J | 1 |
Schlaphoff, V | 1 |
Cornberg, M | 1 |
Ferenci, P | 1 |
Grattagliano, I | 1 |
Palmieri, VO | 1 |
Portincasa, P | 1 |
Palasciano, G | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Multicenter Randomised Study Comparing the Efficacy of PegIFN-alfa2a Plus Placebo vs. PegIFN-alfa2a Plus Tenofovir for the Treatment of Chronic Delta Hepatitis-The Hep-Net International Delta Hepatitis Interventional Trial II (HIDIT-II)[NCT00932971] | Phase 2 | 70 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 reviews available for adenine and Chronic Delta Hepatitis
Article | Year |
---|---|
Treatment of delta hepatitis.
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Farnesyl-Diphosphate Farnesyltransferase; Hepa | 2013 |
An update on hepatitis B, D, and E viruses.
Topics: Adenine; Drug Therapy, Combination; Guanine; Hepatitis B, Chronic; Hepatitis D, Chronic; Hepatitis E | 2014 |
Treatment of chronic viral hepatitis.
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; He | 2004 |
3 trials available for adenine and Chronic Delta Hepatitis
Article | Year |
---|---|
Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome.
Topics: Adenine; Adult; Antiviral Agents; Biopsy; DNA, Viral; Female; Hepatitis B Surface Antigens; Hepatiti | 2015 |
Peginterferon plus adefovir versus either drug alone for hepatitis delta.
Topics: Adenine; Adult; Aged; Alanine Transaminase; Analysis of Variance; Antiviral Agents; Drug Therapy, Co | 2011 |
Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment.
Topics: Adenine; Adult; Analysis of Variance; Antiviral Agents; Cells, Cultured; Chi-Square Distribution; Cy | 2011 |
9 other studies available for adenine and Chronic Delta Hepatitis
Article | Year |
---|---|
Resolution of chronic hepatitis delta infection after five years of peginterferon-adefovir: lessons from a case report.
Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Hepatitis D, Chronic; Hepatitis de | 2013 |
[Diagnosis and treatment of chronic hepatitis B and D. Hungarian national consensus guideline].
Topics: Adenine; Antiviral Agents; Consensus; Drug Administration Schedule; Drug Therapy, Combination; Evide | 2014 |
Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients.
Topics: Adenine; Adult; Antiviral Agents; Hepatitis D, Chronic; HIV Infections; Humans; Liver Cirrhosis; Mal | 2014 |
Cost-Effectiveness of Peg-Interferon, Interferon and Oral Nucleoside Analogues in the Treatment of Chronic Hepatitis B and D Infections in China.
Topics: Adenine; Adult; Age Factors; Aged; Antiviral Agents; China; Cohort Studies; Cost of Illness; Cost-Be | 2016 |
Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation.
Topics: Adenine; Adult; Antiviral Agents; Coinfection; DNA, Viral; Drug Therapy, Combination; Female; Guanin | 2016 |
[Atazanavir-induced nephrolithiasis].
Topics: Adenine; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Cy | 2009 |
Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine.
Topics: Adenine; Antibodies, Viral; Antiviral Agents; Deoxycytidine; DNA, Viral; Drug Therapy, Combination; | 2010 |
Liver fibrosis changes in HIV-HBV-coinfected patients: clinical, biochemical and histological effect of long-term tenofovir disoproxil fumarate use.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cohort | 2010 |
Adefovir dipivoxyl for the treatment of delta-related liver cirrhosis.
Topics: Adenine; Female; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Liver Cirrhosis; Middle Aged; | 2006 |